Impact of malignancy on outcomes in European patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in Atrial Fibrillation General Long-Term Registry

Results

Naziv :	Impact of malignancy on outcomes in European patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in Atrial Fibrillation General Long-Term Registry
Autori:	Malavasi, Vincenzo Livio; Vitolo, Marco; Proietti, Marco; Fauchier, Laurent; Marin, Francisco; Nabauer, Michael; Potpara, Tatjana S. ; Dan, Gheorghe-Andrei; Kalarus, Zbigniew; Lane, Deirdre A.; Lip, Gregory Y. H.; Boriani, Giuseppe;
Godina:	2021
Publikacija:	European heart journal (ESC Congress 2021 – The Digital Experience 27 August – 30 August 2021 Abstract Supplement)
ISSN:	0195-668X European Heart Journal Pretraži identifikator
Izdavač:	Oxford : Oxford University Press
Tip rezultata:	Konferencijski rad
Kolacija:	vol. 42 br. Supplement_1 str. 2862-2862
DOI:	10.1093/eurheartj/ehab724.2862
WoS-ID:	000720456903163
URI:	https://enauka.gov.rs/handle/123456789/827789
URL:	https://academic.oup.com/eurheartj/article/42/Supplement_1/ehab724.2862/6392502?searchresult=1
Projekat:	Abbott Laboratories Amgen Cardiovascular AstraZeneca Bayer AG Boehringer Ingelheim Boston Scientific Bristol-Myers Squibb Pfizer Alliance Alliance Daiichi
Izvor metapodataka:	(Preuzeto iz Nasi u WoS)
M-kategorija:	Mp kategorija će biti prikazana naknadno.

Altmetric

Dimensions

Unpaywall

Google Scholar^TM